Showing results (81-90 of 485) with videos related to
Sort By:
Pageof 49
Expert Review of Anticancer Therapy|July 13, 2002
Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatmentJ Michael DixonInternational Journal of STD & AIDS|November 20, 2003
HIV and AIDS in the People's Republic of China: a collaborative reviewSimon Portsmouth, Justin Stebbing, Xu Keyi, et al.Cellular Signalling|February 15, 2012
The role of pseudokinases in cancerHua Zhang, Andrew Photiou, Arnhild Grothey, et al.Current Drug Safety|August 12, 2008
Host pharmacogenetics in the treatment of HIV and cancerAlan Winston, Eleftheria Hatzimichael, Vanessa Marvin, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 1, 2007
Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramersPhilip Savage, Maggie Millrain, Sofia Dimakou, et al.Communications Biology|July 13, 2024
CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growthTom Stiff, Salih Bayraktar, Paola Dama, et al.Expert Review of Anticancer Therapy|May 11, 2011
Outcomes in unresectable and locally advanced resected cholangiocarcinomaSarah J L Payne, Justin Stebbing, Peter Wilson, et al.Expert Review of Molecular Diagnostics|November 24, 2015
Single-cell sequencing in cancer researchMireia Mato Prado, Adam E Frampton, Justin Stebbing, et al.Expert Review of Proteomics|October 28, 2014
Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancerHua Zhang, Yichen Xu, Panos Papanastasopoulos, et al.Data in Brief|April 8, 2016
Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancerNicos Angelopoulos, Justin Stebbing, Yichen Xu, et al.Pageof 49